Infection by Hepatitis Delta Virus

Hepatitis delta virus (HDV) and hepatitis B virus (HBV) are blood-borne viruses that infect human hepatocytes and cause significant liver disease. Infections with HBV are more damaging when there is a coinfection with HDV. The genomes and modes of replication of these two viruses are fundamentally different, except for the fact that, in nature, HDV replication is dependent upon the envelope proteins of HBV to achieve assembly and release of infectious virus particles, ones that use the same host cell receptor. This review focuses on what has been found of the various ways, natural and experimental, by which HDV particles can be assembled and released. This knowledge has implications for the prevention and treatment of HDV infections, and maybe for an understanding of the origin of HDV.

[1]  M. Kann,et al.  ICTV Virus Taxonomy Profile: Hepadnaviridae , 2020, The Journal of general virology.

[2]  S. Müller,et al.  Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication , 2020, Nature Communications.

[3]  C. Schuster,et al.  Targeting the Host for New Therapeutic Perspectives in Hepatitis D , 2020, Journal of clinical medicine.

[4]  M. Buti,et al.  Editorial: rapid disease progression in hepatitis delta—can we turn the tide? Authors' reply , 2020, Alimentary pharmacology & therapeutics.

[5]  M. Peppelenbosch,et al.  Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection , 2019, The Journal of infectious diseases.

[6]  J. Hepojoki,et al.  Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles , 2019, mBio.

[7]  F. Cosset,et al.  Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo , 2019, Nature Communications.

[8]  J. Hepojoki,et al.  Identification of a Novel Deltavirus in Boa Constrictors , 2019, mBio.

[9]  J. Casey,et al.  Hepatitis Delta Antigen Regulates mRNA and Antigenome RNA Levels during Hepatitis Delta Virus Replication , 2019, Journal of Virology.

[10]  Senko Tsukuda,et al.  Concept of Viral Inhibitors via NTCP , 2019, Seminars in Liver Disease.

[11]  M. Shi,et al.  A Divergent Hepatitis D-Like Agent in Birds , 2018, bioRxiv.

[12]  A. Vaillant.  REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection. , 2018, ACS infectious diseases.

[13]  R. Jhaveri,et al.  Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa. , 2018, The Journal of infectious diseases.

[14]  Abdurrahman Sahin,et al.  Treatment of Delta Hepatitis: Today and in the Future - A review , 2017, Infectious diseases.

[15]  Yan Zhou,et al.  HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant. , 2016, Gastroenterology.

[16]  Thorsten Lehr,et al.  Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study. , 2016, Journal of hepatology.

[17]  A. Lohse,et al.  Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. , 2015, Journal of hepatology.

[18]  C. Seeger,et al.  Molecular biology of hepatitis B virus infection. , 2015, Virology.

[19]  S. Chasovskikh,et al.  Hepatitis Delta Antigen Requires a Flexible Quasi-Double-Stranded RNA Structure To Bind and Condense Hepatitis Delta Virus RNA in a Ribonucleoprotein Complex , 2014, Journal of Virology.

[20]  S. Gudima,et al.  Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles , 2014, Journal of Virology.

[21]  S. Polywka,et al.  Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. , 2014, Journal of hepatology.

[22]  Wenhui Li,et al.  NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry , 2014, International journal of molecular sciences.

[23]  M. Tschapka,et al.  Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes , 2013, Proceedings of the National Academy of Sciences.

[24]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[25]  M. Lai,et al.  Hepatitis Delta Virus RNA Replication , 2009, Viruses.

[26]  E. Nicolas,et al.  Assembly of Hepatitis Delta Virus: Particle Characterization, Including the Ability To Infect Primary Human Hepatocytes , 2007, Journal of Virology.

[27]  P. Casey,et al.  The Hepatitis Delta Virus Large Antigen Is Farnesylated Both in Vitro and in Animal Cells (*) , 1996, The Journal of Biological Chemistry.

[28]  J. Taylor,et al.  Introduction of hepatitis delta virus into animal cell lines via cationic liposomes , 1994, Journal of virology.

[29]  J. Taylor,et al.  Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging , 1994, Journal of virology.

[30]  Ding‐Shinn Chen,et al.  The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Taylor,et al.  In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells , 1990, Journal of virology.

[32]  J. Taylor,et al.  Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen , 1989, Journal of virology.

[33]  J. Taylor,et al.  Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus , 1988, Journal of virology.

[34]  J. Taylor,et al.  Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage , 1988, Journal of virology.

[35]  J. Taylor,et al.  Structure and replication of the genome of hepatitis delta virus. , 1986, Progress in clinical and biological research.

[36]  H. Schellekens,et al.  The hepatitis delta (δ) virus possesses a circular RNA , 1986, Nature.

[37]  Michael Houghton,et al.  Structure, sequence and expression of the hepatitis delta (δ) viral genome , 1986, Nature.

[38]  J. Coura,et al.  [Labrea hepatitis. Review study of hepatic viscerotomies from 1934 to 1940]. , 1985, Revista do Instituto de Medicina Tropical de Sao Paulo.

[39]  R. Purcell,et al.  Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Purcell,et al.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. , 1980, The Journal of infectious diseases.

[41]  M. Rizzetto,et al.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. , 1977, Gut.

[42]  J. Casey.  RNA editing in hepatitis delta virus. , 2006, Current topics in microbiology and immunology.

[43]  J. Glenn.  Prenylation of HDAg and antiviral drug development. , 2006, Current topics in microbiology and immunology.

[44]  C. Sureau.  The role of the HBV envelope proteins in the HDV replication cycle. , 2006, Current topics in microbiology and immunology.

[45]  C. Seeger,et al.  Hepadnaviruses , 1991, Current Topics in Microbiology and Immunology.

[46]  B. Tennant,et al.  Hepadnavirus-induced liver cancer in woodchucks. , 1989, Cancer detection and prevention.

[47]  Ding‐Shinn Chen,et al.  The large form of hepatitis 6 antigen is crucial for assembly of hepatitis 6 virus , 2022 .